Pentao LIU
Senior Group Leader, Wellcome Trust Sanger Institute, UK

Dr. Liu graduate from Henan Normal University. He obtained his M.Sc from Chinese Academy of Sciences and Institute of Genetics. He received a Ph.D. from Baylor College of Medicine (Houston, Texas, USA). Dr. Liu did his postdoc training at National Cancer Institute (Maryland, USA). He joined the faculty of Wellcome Trust Sanger Institute in 2003 and is currently a Senior Group Leader. Dr. Liu's laboratory is working on several research areas: mouse genetics, stem cells, immunity and cancer. His lab discovered a new type of cancer killing cells which may have clinical applications. Dr. Liu's team developed a new technology to rapidly and efficiently reprogramme mouse and human somatic cells to iPS cells, and identified PD-1 on activated innate lymphoid cells. Dr. Liu's lab have been in recent years focusing on establishing cultures of totipotent stem cells of mouse and other mammals including human and farm animals. Dr. Liu's lab has participated in several major research initiatives funded by the EU and NIH.